Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury

  • Yoon-Kyung Chang,
  • Hyunsu Choi,
  • Jin Young Jeong,
  • Ki-Ryang Na,
  • Kang Wook Lee,
  • Beom Jin Lim,
  • Dae Eun Choi
  • Article
  • Metrics
  • Comments
  • Media Coverage

The affiliation for the sixth author, Beom Jin Lim, is spelled incorrectly. The correct affiliation is: Department of Pathology, College of Medicine, Yonsei University, Seoul, South Korea.

Reference

  1. 1. Chang Y-K, Choi H, Jeong JY, Na K-R, Lee KW, Lim BJ, et al. (2016) Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury. PLoS ONE 11(7): e0158810. pmid:27391020

Citation: Chang Y-K, Choi H, Jeong JY, Na K-R, Lee KW, Lim BJ, et al. (2016) Correction: Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury. PLoS ONE 11(7): e0160478. https://doi.org/10.1371/journal.pone.0160478

Published: July 28, 2016

Copyright: © 2016 Chang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.